- Home
- WEYS vs ETON Comparison
WEYS vs ETON Comparison
Compare WEYS & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WEYS
- ETON
- Stock Information
- Founded
- WEYS 1906
- ETON 2017
- Country
- WEYS United States
- ETON United States
- Employees
- WEYS N/A
- ETON N/A
- Industry
- WEYS Apparel
- ETON Biotechnology: Pharmaceutical Preparations
- Sector
- WEYS Consumer Staples
- ETON Health Care
- Exchange
- WEYS Nasdaq
- ETON Nasdaq
- Market Cap
- WEYS 341.7M
- ETON 329.8M
- IPO Year
- WEYS N/A
- ETON 2018
- Fundamental
- Price
- WEYS $30.08
- ETON $12.76
- Analyst Decision
- WEYS
- ETON Strong Buy
- Analyst Count
- WEYS 0
- ETON 3
- Target Price
- WEYS N/A
- ETON $27.67
- AVG Volume (30 Days)
- WEYS 14.9K
- ETON 222.8K
- Earning Date
- WEYS 03-04-2025
- ETON 03-18-2025
- Dividend Yield
- WEYS 10.11%
- ETON N/A
- EPS Growth
- WEYS N/A
- ETON N/A
- EPS
- WEYS 3.16
- ETON N/A
- Revenue
- WEYS $290,290,000.00
- ETON $39,011,000.00
- Revenue This Year
- WEYS N/A
- ETON $107.69
- Revenue Next Year
- WEYS N/A
- ETON $65.50
- P/E Ratio
- WEYS $9.65
- ETON N/A
- Revenue Growth
- WEYS N/A
- ETON 23.29
- 52 Week Low
- WEYS $27.05
- ETON $3.03
- 52 Week High
- WEYS $41.05
- ETON $18.41
- Technical
- Relative Strength Index (RSI)
- WEYS 41.19
- ETON 36.21
- Support Level
- WEYS $29.83
- ETON $12.24
- Resistance Level
- WEYS $31.38
- ETON $13.64
- Average True Range (ATR)
- WEYS 0.87
- ETON 0.92
- MACD
- WEYS 0.25
- ETON -0.18
- Stochastic Oscillator
- WEYS 62.64
- ETON 14.90
About WEYS Weyco Group Inc.
Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale and the North American retail segment. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, Asia, South Africa, and Australia.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.